📌 Key Takeaways
- Topic: Tosoh Silica: Product Range, Applications and Key Grades
- Keywords: fumed silica supplier
- Published: 2026-11-20 03:42:54
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Clinical trials involving mesoporous silica have been ongoing since 2007, discussing its potential in diverse biomedical applications (Table 3 ). To date, the clinical trials have revealed the safety and good tolerability of silica in human subjects. In 2014, MSNs as oral delivery carriers for boosting the pharmacokinetic profile of drugs with limited aqueous solubility were reported. 500 A silica NPs-lipid hybrid formulation loading with ibuprofen (Lipoceramic-IBU) was prepared. The randomized, double-blind, single-dose oral administration study (20 mg ibuprofen) was conducted on 16 healthy male volunteers. The bioavailability of Lipoceramic-IBU was found to be 1.95 times higher than that of the commercial tablet Nurofen. 500 This result suggested the secure and effective use of silica-based NPs in mimicking food impacts to optimize the oral absorption of drugs with poor water solubility. In another clinical trial consisting of 12 participants in 2016, the bioavailability of ordered MSNs-based fenofibrate formulation raised by 54.1% after a single oral dose, when compared to the commercial formulation Lipanthyl. 39 Owing to the potentially perfect clinical outcomes of silica-based nanocarriers, the pharmacokinetics, safety, and metabolic profile of a hybrid core-shell silica NP (named Cornell dots, C dots) with a diameter of 6 nm functionalized with 124 I, targeting peptide cyclo-(Arg-Gly-Asp-Tyr), and Cy5 ( 124 I-cRGDY-PEG-C' dots) is first conducted in humans utilizing PET imaging and clinical tracer at clinical trials in 2014 (NCT01266096). 58 Results showed the good safety and reproducible PK signatures of C dots with the whole-body clearance half-time of 13-21 h after intravenous administration in patients, which is shorter than 111 In labeled liposomes and 131 I-labeled humanized monoclonal antibody A33. These findings verified the possibility of these NPs for cancer diagnostics in humans. 58 Similarly, 8 nm core-shell silica NPs encapsulated with Cy5.5 in the core and connected with cRGDY on the surface (cRGDY-PEG-Cy5.5-nanoparticles) were used in patients at nanomole doses for sentinel lymph nodes detection of head and neck melanoma at a phase 1/2 human clinical trial. 501 The incredible safety, accuracy, reliability, and high contrast of these particles for visual identification of sentinel lymph nodes are irreplaceable by other available imaging molecules presently, of which phase 2 clinical trial is ongoing and will be finished in 2024 (NCT02106598). Meanwhile, another two clinical trials based on C dots are carried out. In 2018, the 89 Zr-DFO-cRGDY-PEG-Cy5-C' dots tracers were first used in both surgical and non-surgical patients for PET-CT imaging of malignant brain tumors in phase 1 clinical trial (NCT03465618). The distribution and removal profiles from the body of these particles will also be assessed till 2023. In 2019, 64 Cu-NOTA-PSMA-PEG-Cy5.5-C' dots tracer was used in another human phase 1 clinical trial for guiding the surgery of prostate cancer by PET and MRI imaging (NCT04167969).As a nanocomposite with high safety and brilliant photothermal conversion efficiency, the silica-gold NPs have also been shown to be potential therapeutic agents for plasmonic photothermal therapy of atherosclerosis (NCT01270139), 502, 503 and photothermal ablation of tumors (NCT00848042, NCT04240639). 40 In addition, an engineered mesoporous silica (SiPore15) with particle size of 1.1-1.5 μm × 0.2-0.4 μm was developed by Baek et al., and they revealed that such pure synthetic amorphous silica could remarkably decrease long-term blood glucose levels, showing good promise for the treatment of prediabetes (NCT03823027). 504 In other clinical trials, an amorphous silica-containing bioactive scaffold, called Siloss, was used to promote bone regeneration, and could be replaced by natural bone due to its fully resorbable nature (NCT02639572), and the silica-calcium phosphate nanocomposite (SCPC) was developed as graft material for the reconstruction of the volume-deficient alveolar ridges (NCT05317039). In all, these clinical trials reveal the safety and efficacy of MSNs in diverse biomedical application scenarios.
Silica Antiblocking Agent: How It Works, Particle Size Selection and Uses
- Quartz CAS 14808-60-7: Identification, Hazards and Regulatory Information
- Liu, Q. et al. A DNA-based nanodevice for near-infrared light-controlled drug release and bioimaging. Nano Today 48, 101747 (2023). Piece CAS Google Scholar
- Alkaline Silica Sol: Properties, pH Range and Industrial Uses
- The pH in normal tissues under physiological conditions is typically neutral, while in solid tumors, the tumor microenvironment is normally slightly acidic due to the exuberant metabolism of tumor cells that results in the production of sizable amounts of lactic acid. 337, 338 Therefore, the construction of pH-responsive MSNs nanocarriers can attain targeted drug release and tumor therapy. Wagner et al. functionalized the external surface of MSNs by carboxylic groups, followed by attaching a stimuli-responsive capping system, that consists of a pH-responsive acetal linker and a biotin-avidin gatekeeper. 339 After uptaken by lysosome in tumor environment, the biotin-avidin caps were separated out and the immune-stimulant R848 (resiquimod) could be released, thus achieving improved targeted delivery of immune modulator to antigen-presenting cells. 339 Besides, in the construction of a light-responsive drug delivery system, Zhao et al. grafted the light-responsive azobenzene group on the surface of biodegradable MSNs, and β-cyclodextrin-modified polymer as the cap agent. In vitro experiments verified that the visible light triggered the isomerization of azobenzene, followed by the dissociation of CD-PMPC from MSNs surface and following drug release. The excellent anti-inflammatory effect of MSNs-based platform shown their potential in the treatment of osteoarthritis. 274 Regarding enzyme-responsive drug delivery system, some researchers reported the synthesis of MSNs attached with chitosan gatekeeper via azo bonds. The azo bonds could be cleaved by the colon-specific enzyme, leading to the separation of chitosan gatekeeper and the release of DOX. 334 In all, these functionalized MSNs-based drug delivery systems that specifically respond multiple stimulus signals provide a precisely localized and targeted way for illness treatments.
- Syloid Silica: Matting, Excipient and Food Grades Explained, with Alternatives
- FDU-series mesoporous silica is largely represented by FDU-1, FDU-2, FDU-5, and FDU-12, firstly reported by Zhao's group from Fudan University. 91 All of these possess 3D mesoporous architectures, well-ordered pore arrangements, amorphous pore wall structures and excellent thermal and mechanical stability. 62 The first FDU-series MSN to be synthesized was FDU-1 in 2000, which has an Im 3̄ m space-group symmetry and exhibits a comparable mesoporous structure to SBA-16. 91 Unlike the SBA- and MCM-series MSNs, the FDU series have few bioapplications, and there are only a few reports of FDU-12 in the field of drug delivery. 92, 93 FDU-12 presents 3D cubic mesostructure with Fm 3̄ m space-group symmetry, and possesses a big cavity (10-12.3 nm), whose entrance sizes can be regulated in the range of ≈ 4-9 nm. 94
- Bulk Silica Powder: Packaging Options, MOQ and Bulk Pricing Guide
- Huang, C. et al. Robust nanovaccine based on polydopamine‐coated mesoporous silica nanoparticles for effective photothermal‐immunotherapy against melanoma. Adv. Funct. Mater. 31, 2010637 (2021). Article CAS Google Scholar
Pharmaceutical Grade Silica: Specifications, USP/EP Standards and Uses as an Excipient
What is silica (SiO₂)?
Nouryon Levasil
What is the difference between fumed silica and precipitated silica?
fumed silica price Fang, W., Yang, J., Gong, J. & Zheng, N. Photo‐and pH‐triggered release of anticancer drugs from mesoporous silica‐coated Pd@Ag nanoparticles. Adv. Funct. Mater. 22, 842-848 (2012). Post CAS Google Scholar
What drives silica raw material prices?
silica manufacturer Huo, M. et al. Upconversion nanoparticles hybridized cyanobacterial cells for near‐infrared mediated photosynthesis and improved photodynamic therapy. Adv. Funct. Mater. 31, 2010196 (2021). Post CAS Google Scholar
Cite this article: Silica Raw Materials News. "Silica Aerogel Blanket: Thermal Conductivity, Thickness Options and Insulation Uses
." Published 2026-11-20 03:42:54.
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.